Home › Funds › 325 CAPITAL LLC › ASTH

325 CAPITAL LLC position in ASTH

ASTRANA HEALTH INC · Consumer Discretionary

325 CAPITAL LLC reported holding 1,613,843 shares of ASTH (ASTRANA HEALTH INC) in its Q2 2026 13F filing — a position valued at US$74.9M, representing 17.85% of its reported portfolio and ranking #1 among its reported holdings. 325 CAPITAL LLC has disclosed ASTH holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)1.61M sh
Reported value held$74.90M
Portfolio Weight17.85%
First reportedQ3 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How 325 CAPITAL LLC's ASTH position evolved

325 CAPITAL LLC first disclosed a stake in ASTH in Q3 2023 at 592,810 shares (US$18.3M). The position peaked in Q2 2026 at 1,613,843 shares, worth US$74.9M. Across 12 filings, 325 CAPITAL LLC increased the stake 5 time(s), trimmed it 1 time(s) and left it unchanged 5 time(s). The most recent filing (Q2 2026) shows 1,613,843 shares valued at US$74.9M — a reduction of -225,233 shares quarter over quarter.. Notable position changes include a 30% increase in Q4 2024 (shares fell 2% over the following quarter), a 35% increase in Q3 2025 (shares fell 12% over the following quarter), a 54% increase in Q4 2025 (shares fell 1% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 592.81K $18.29M New
Q4 2023 592.81K $22.70M Hold
Q1 2024 592.81K $24.89M Hold
Q2 2024 621.35K $25.20M Add
Q3 2024 680.91K $39.45M Add
Q4 2024 886.92K $27.96M Add
Q1 2025 886.92K $27.50M Hold
Q2 2025 886.92K $22.07M Hold
Q3 2025 1.19M $33.85M Add
Q4 2025 1.84M $45.63M Add
Q1 2026 1.84M $45.09M Hold
Q2 2026 1.61M $74.90M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ASTH and 13F data

ASTH (ASTRANA HEALTH INC) is a Consumer Discretionary company. 46 other funds we track also report a position in ASTH — the largest reported positions include SteelPeak Wealth, LLC (US$15.5M), 683 Capital Management, LLC (US$9.7M), 1492 Capital Management LLC (US$6.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ASTH

All ASTH fund holders →

FAQ

How long has 325 CAPITAL LLC held ASTH?

325 CAPITAL LLC has disclosed ASTH holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is 325 CAPITAL LLC's current position in ASTH?

As of Q2 2026, 325 CAPITAL LLC holds 1.61M shares of ASTH (ASTRANA HEALTH INC), valued at $74.90M, representing 17.85% of its reported portfolio and ranking #1.

Has 325 CAPITAL LLC been buying or selling ASTH?

In the latest 13F filing (Q2 2026), 325 CAPITAL LLC reduced its position in ASTH. The position peaked in Q2 2026 at 1.61M shares.

Which other funds hold ASTH?

Other major institutional holders of ASTH include SteelPeak Wealth, LLC, 683 Capital Management, LLC, 1492 Capital Management LLC, among 46 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.